Inogen, in collaboration with Yuwell, will now have a stationary oxygen concentrator to package with its portable oxygen concentrator, giving its sales organization “more productivity ...

Q4 2024 Earnings Call Transcript February 25, 2025 Inogen, Inc. beats earnings expectations. Reported EPS is $-0.41, ...

Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with ...

We entered into this collaboration in January 2025. As part of the agreement, UL would distribute Inogen portable oxygen concentrators under the Inogen brand in China, expediting our entry into ...

Inogen, Inc. (NASDAQ: INGN) is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter ...

Cost optimization through ... Additionally, Inogen's recent product innovation, including the launch of the Rove 4 portable oxygen concentrator, is likely to have brought additional revenues ...

Cost optimization through ... Additionally, Inogen's recent product innovation, including the launch of the Rove 4 portable oxygen concentrator, is likely to have brought additional revenues ...

As the fourth-quarter earnings season almost comes to an end, this week will be crucial for a few companies in the medical ...

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share. The produces oxygen concentrators for ...

GOLETA, Calif. - Inogen reported total revenue of $80.1 million for the fourth quarter of 2024, a 5.5% increase compared to ...